Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Adrenal Cortex Cancer

thiazoles has been researched along with Adrenal Cortex Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benhida, R; Doghman-Bouguerra, M; Lalli, E; Rocchi, S; Ronco, C; Ruggiero, C1
Avena, P; Campana, C; Cappello, AR; Casaburi, I; Chimento, A; De Luca, A; Domanico, F; Fiorillo, M; Lisanti, MP; Malivindi, R; Pezzi, V; Rago, V; Sirianni, R; Sotgia, F1
Cowell, S; Guns, E; Mutarapat, T; Nelson, C; Nijmeijer, S; Renaud, M; Ruchirawat, S; Sanderson, T; Scholten, D; van den Berg, M1

Other Studies

3 other study(ies) available for thiazoles and Adrenal Cortex Cancer

ArticleYear
The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways.
    Molecular and cellular endocrinology, 2018, 10-15, Volume: 474

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Dehydroepiandrosterone Sulfate; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Humans; Hydrocortisone; Mitotane; Sulfonamides; Thiazoles

2018
Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).
    Oncotarget, 2015, Sep-22, Volume: 6, Issue:28

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antineoplastic Agents, Hormonal; Autophagy; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Partial Agonism; Energy Metabolism; ERRalpha Estrogen-Related Receptor; G1 Phase Cell Cycle Checkpoints; Humans; Mice, Nude; Mitochondria; Molecular Targeted Therapy; Necrosis; Nitriles; Receptors, Estrogen; Signal Transduction; Thiazoles; Time Factors; Xenograft Model Antitumor Assays

2015
Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells.
    European journal of pharmacology, 2008, Sep-28, Volume: 593, Issue:1-3

    Topics: Adrenal Cortex Neoplasms; Androgen Receptor Antagonists; Androgens; Aromatase Inhibitors; Cell Line, Tumor; Cyclic AMP; Data Interpretation, Statistical; Genes, Reporter; Humans; Lactones; Luciferases; Male; Prostatic Neoplasms; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Transfection

2008